EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 32010R1238
Regulation (EU) No 1238/2010 of the European Parliament and of the Council of 15 December 2010 amending Annex I to Council Regulation (EEC) No 2658/87 as regards the provision of duty-free treatment for specified pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals
Regulation (EU) No 1238/2010 of the European Parliament and of the Council of 15 December 2010 amending Annex I to Council Regulation (EEC) No 2658/87 as regards the provision of duty-free treatment for specified pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals
Regulation (EU) No 1238/2010 of the European Parliament and of the Council of 15 December 2010 amending Annex I to Council Regulation (EEC) No 2658/87 as regards the provision of duty-free treatment for specified pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals
OJ L 348, 31.12.2010, p. 36–73
(BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
In force
|
31.12.2010 |
EN |
Official Journal of the European Union |
L 348/36 |
REGULATION (EU) No 1238/2010 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
of 15 December 2010
amending Annex I to Council Regulation (EEC) No 2658/87 as regards the provision of duty-free treatment for specified pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals
THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION,
Having regard to the Treaty on the Functioning of the European Union, and in particular Article 207 thereof,
Having regard to the proposal from the European Commission,
After transmission of the draft legislative act to the national parliaments,
Acting in accordance with the ordinary legislative procedure (1),
Whereas:
|
(1) |
In the course of the Uruguay Round negotiations, the Community and a number of countries agreed that duty-free treatment should be granted to pharmaceutical products falling within the Harmonised System (HS) Chapter 30 and HS headings 2936, 2937, 2939 and 2941 as well as to designated pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organization, specified salts, esters and hydrates of such INNs, and designated pharmaceutical intermediates used for the production and manufacture of finished pharmaceuticals. |
|
(2) |
The results of the discussions, as set out in the Record of Discussions, were incorporated into the tariff schedules of the participants annexed to the Marrakesh Protocol to the General Agreement on Tariffs and Trade (GATT) 1994. |
|
(3) |
Participants concluded that representatives of World Trade Organization (WTO) members, party to the Record of Discussions, would meet under the auspices of the Council for Trade in Goods of the WTO, normally at least once every three years, to review the product coverage with a view to including, by consensus, additional pharmaceutical products for tariff elimination. |
|
(4) |
Three such reviews have taken place with the result that a certain number of additional INNs and pharmaceutical intermediates used for the production and manufacture of finished pharmaceuticals have been granted duty-free treatment, that some of those intermediates have been transferred to the list of INNs, and that the list of specified prefixes and suffixes for salts, esters or hydrates of INNs has been expanded. |
|
(5) |
A fourth review was deemed appropriate and was launched in 2009. It concluded that a certain number of additional INNs and pharmaceutical intermediates used for the production and manufacture of finished pharmaceuticals should be granted duty-free treatment, that some of those intermediates already included in the pharmaceutical sectoral arrangement and its revisions should be transferred to the list of INNs, and that the list of specified prefixes and suffixes for salts, esters or hydrates of INNs should be expanded. |
|
(6) |
Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs Tariff (2) established the Combined Nomenclature (CN) and set out the conventional duty rates of the Common Customs Tariff. |
|
(7) |
Regulation (EEC) No 2658/87 should therefore be amended accordingly. |
|
(8) |
In order to ensure that the measures provided for in this Regulation apply from 1 January 2011, it should enter into force on the day following that of its publication, |
HAVE ADOPTED THIS REGULATION:
Article 1
Annexes 3, 4 and 6 of Section II of Part Three of Annex I to Regulation (EEC) No 2658/87 (Lists of pharmaceutical substances which qualify for duty-free treatment) are hereby amended as follows:
|
1. |
As from 1 January 2011 the Union shall extend duty-free treatment to the INNs listed in Annex I. |
|
2. |
As from 1 January 2011 the list of prefixes and suffixes which, in combination with the INNs included in the pharmaceutical sectoral arrangement and its revisions, describe the salts, esters or hydrates of INNs which are also eligible for duty-free treatment, on condition that they are classifiable in the same six-digit HS subheading as the corresponding INN, shall be amended as set out in Annex II. |
|
3. |
As from 1 January 2011 the Union shall extend duty-free treatment to the pharmaceutical intermediates used in the production and manufacture of finished pharmaceuticals, listed in Annex III. |
|
4. |
As from 1 January 2011 the pharmaceutical intermediates listed in Annex IV shall be withdrawn from the list of such compounds receiving duty-free treatment. |
Article 2
This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union.
It shall apply from 1 January 2011.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Strasbourg, 15 December 2010.
For the European Parliament
The President
J. BUZEK
For the Council
The President
O. CHASTEL
(1) Position of the European Parliament of 23 November 2010 (not yet published in the Official Journal) and decision of the Council of 10 December 2010.
ANNEX I
List of international non-proprietary names (INNs) to be added to the list of products receiving duty-free treatment included in Annex 3 to Annex I to Regulation (EEC) No 2658/87
|
CN code |
CAS RN |
Name |
|
2842 90 80 |
119175-48-3 |
fermagate |
|
2843 90 90 |
759457-82-4 |
padeliporfin |
|
2844 40 30 |
123748-56-1 |
iodofiltic acid (
|
|
2904 10 00 |
21668-77-9 |
eprodisate |
|
2906 19 00 |
199798-84-0 |
elocalcitol |
|
2909 30 90 |
24150-24-1 |
terameprocol |
|
2916 19 95 |
81485-25-8 |
peretinoin |
|
2916 39 00 |
51543-40-9 |
tarenflurbil |
|
2918 19 98 |
174022-42-5 |
bevirimat |
|
2919 90 00 |
258516-89-1 |
fospropofol |
|
2920 90 85 |
163133-43-5 |
naproxcinod |
|
2921 19 99 |
3687-18-1 |
tramiprosate |
|
2922 19 85 |
68392-35-8 |
afimoxifene |
|
2922 19 85 |
753449-67-1 |
ronacaleret |
|
2922 29 00 |
433265-65-7 |
faxeladol |
|
2922 50 00 |
121524-08-1 |
amibegron |
|
2922 50 00 |
329773-35-5 |
cinaciguat |
|
2922 50 00 |
643094-49-9 |
fasobegron |
|
2923 10 00 |
856676-23-8 |
choline fenofibrate |
|
2924 29 98 |
847353-30-4 |
arbaclofen placarbil |
|
2924 29 98 |
194785-19-8 |
bedoradrine |
|
2924 29 98 |
194085-75-1 |
carisbamate |
|
2924 29 98 |
254750-02-2 |
emricasan |
|
2924 29 98 |
355129-15-6 |
eprotirome |
|
2924 29 98 |
402567-16-2 |
firategrast |
|
2924 29 98 |
478296-72-9 |
gabapentin enacarbil |
|
2924 29 98 |
15866-90-7 |
incyclinide |
|
2924 29 98 |
202844-10-8 |
indantadol |
|
2924 29 98 |
96847-55-1 |
levomilnacipran |
|
2924 29 98 |
608137-32-2 |
lisdexamfetamine |
|
2924 29 98 |
652990-07-3 |
milveterol |
|
2924 29 98 |
181816-48-8 |
ombrabulin |
|
2924 29 98 |
289656-45-7 |
senicapoc |
|
2925 19 95 |
19171-19-8 |
pomalidomide |
|
2928 00 90 |
22033-87-0 |
olesoxime |
|
2928 00 90 |
2675-35-6 |
sivifene |
|
2928 00 90 |
816458-31-8 |
tecovirimat |
|
2928 00 90 |
238750-77-1 |
tosedostat |
|
2928 00 90 |
149647-78-9 |
vorinostat |
|
2929 90 00 |
31645-39-3 |
palifosfamide |
|
2930 90 99 |
608141-41-9 |
apremilast |
|
2930 90 99 |
216167-92-9 |
camobucol |
|
2930 90 99 |
211513-37-0 |
dalcetrapib |
|
2930 90 99 |
69819-86-9 |
darinaparsin |
|
2930 90 99 |
488832-69-5 |
elesclomol |
|
2930 90 99 |
216167-95-2 |
elsibucol |
|
2930 90 99 |
168682-53-9 |
ezatiostat |
|
2930 90 99 |
58569-55-4 |
metenkefalin |
|
2930 90 99 |
887148-69-8 |
monepantel |
|
2930 90 99 |
603139-19-1 |
odanacatib |
|
2930 90 99 |
162520-00-5 |
salirasib |
|
2930 90 99 |
216167-82-7 |
succinobucol |
|
2930 90 99 |
125961-82-2 |
tipelukast |
|
2931 00 99 |
125973-56-0 |
amsilarotene |
|
2932 19 00 |
253128-41-5 |
eribulin |
|
2932 19 00 |
186953-56-0 |
pafuramidine |
|
2932 29 85 |
195883-06-8 |
omtriptolide |
|
2932 99 00 |
664338-39-0 |
arterolane |
|
2932 99 00 |
183133-96-2 |
cabazitaxel |
|
2932 99 00 |
401925-43-7 |
celivarone |
|
2932 99 00 |
461432-26-8 |
dapagliflozin |
|
2932 99 00 |
118457-15-1 |
dexnebivolol |
|
2932 99 00 |
156294-36-9 |
larotaxel |
|
2932 99 00 |
118457-16-2 |
levonebivolol |
|
2932 99 00 |
83461-56-7 |
mifamurtide |
|
2932 99 00 |
117570-53-3 |
vadimezan |
|
2933 19 90 |
496775-61-2 |
eltrombopag |
|
2933 19 90 |
206884-98-2 |
niraxostat |
|
2933 19 90 |
410528-02-8 |
palovarotene |
|
2933 19 90 |
376592-42-6 |
totrombopag |
|
2933 29 90 |
183659-72-5 |
catramilast |
|
2933 29 90 |
944263-65-4 |
demiditraz |
|
2933 29 90 |
867153-61-5 |
dulanermin |
|
2933 29 90 |
320367-13-3 |
lixisenatide |
|
2933 29 90 |
698389-00-3 |
rolipoltide |
|
2933 29 90 |
697766-75-9 |
velafermin |
|
2933 39 99 |
147084-10-4 |
alcaftadine |
|
2933 39 99 |
54-96-6 |
amifampridine |
|
2933 39 99 |
249921-19-5 |
anamorelin |
|
2933 39 99 |
319460-85-0 |
axitinib |
|
2933 39 99 |
208110-64-9 |
befiradol |
|
2933 39 99 |
330942-05-7 |
betrixaban |
|
2933 39 99 |
201034-75-5 |
daporinad |
|
2933 39 99 |
209783-80-2 |
entinostat |
|
2933 39 99 |
412950-27-7 |
goxalapladib |
|
2933 39 99 |
218791-21-0 |
imisopasem manganese |
|
2933 39 99 |
103129-82-4 |
levamlodipine |
|
2933 39 99 |
154357-42-3 |
levonadifloxacin |
|
2933 39 99 |
108147-54-2 |
migalastat |
|
2933 39 99 |
453562-69-1 |
motesanib |
|
2933 39 99 |
139145-27-0 |
parogrelil |
|
2933 39 99 |
459856-18-9 |
pexacerfont |
|
2933 39 99 |
706779-91-1 |
pimavanserin |
|
2933 39 99 |
362665-56-3 |
pitolisant |
|
2933 39 99 |
861151-12-4 |
rosonabant |
|
2933 39 99 |
701977-09-5 |
taranabant |
|
2933 39 99 |
189950-11-6 |
tropantiol |
|
2933 39 99 |
793655-64-8 |
vapitadine |
|
2933 39 99 |
139290-65-6 |
volinaserin |
|
2933 49 90 |
141388-76-3 |
besifloxacin |
|
2933 49 90 |
697761-98-1 |
elvitegravir |
|
2933 49 90 |
185055-67-8 |
ferroquine |
|
2933 49 90 |
445041-75-8 |
intiquinatine |
|
2933 49 90 |
378746-64-6 |
nemonoxacin |
|
2933 49 90 |
245765-41-7 |
ozenoxacin |
|
2933 49 90 |
412950-08-4 |
rilapladib |
|
2933 49 90 |
871224-64-5 |
almorexant |
|
2933 49 90 |
863029-99-6 |
balamapimod |
|
2933 49 90 |
698387-09-6 |
neratinib |
|
2933 49 90 |
154652-83-2 |
tezampanel |
|
2933 49 90 |
128253-31-6 |
veliflapon |
|
2933 59 95 |
791828-58-5 |
aderbasib |
|
2933 59 95 |
840486-93-3 |
adipiplon |
|
2933 59 95 |
850649-61-5 |
alogliptin |
|
2933 59 95 |
859212-16-1 |
bafetinib |
|
2933 59 95 |
380843-75-4 |
bosutinib |
|
2933 59 95 |
839712-12-8 |
cariprazine |
|
2933 59 95 |
414910-27-3 |
casopitant |
|
2933 59 95 |
288383-20-0 |
cediranib |
|
2933 59 95 |
849550-05-6 |
cevipabulin |
|
2933 59 95 |
827318-97-8 |
danusertib |
|
2933 59 95 |
356057-34-6 |
darapladib |
|
2933 59 95 |
501000-36-8 |
dutacatib |
|
2933 59 95 |
247257-48-3 |
fimasartan |
|
2933 59 95 |
3432-99-3 |
folitixorin |
|
2933 59 95 |
668270-12-0 |
linagliptin |
|
2933 59 95 |
441798-33-0 |
macitentan |
|
2933 59 95 |
641571-10-0 |
nilotinib |
|
2933 59 95 |
763113-22-0 |
olaparib |
|
2933 59 95 |
686344-29-6 |
otenabant |
|
2933 59 95 |
625115-55-1 |
riociguat |
|
2933 59 95 |
486460-32-6 |
sitagliptin |
|
2933 59 95 |
425637-18-9 |
sotrastaurin |
|
2933 59 95 |
309913-83-5 |
talmapimod |
|
2933 59 95 |
113857-87-7 |
talotrexin |
|
2933 59 95 |
274693-27-5 |
ticagrelor |
|
2933 59 95 |
306296-47-9 |
vicriviroc |
|
2933 69 80 |
775351-65-0 |
imeglimin |
|
2933 79 00 |
461443-59-4 |
aplaviroc |
|
2933 79 00 |
189691-06-3 |
bremelanotide |
|
2933 79 00 |
813452-18-5 |
carmegliptin |
|
2933 79 00 |
405169-16-6 |
dovitinib |
|
2933 79 00 |
536748-46-6 |
eribaxaban |
|
2933 79 00 |
473289-62-2 |
ilepatril |
|
2933 79 00 |
180694-97-7 |
mimopezil |
|
2933 79 00 |
579475-18-6 |
orvepitant |
|
2933 79 00 |
449811-01-2 |
pamapimod |
|
2933 79 00 |
248282-01-1 |
paquinimod |
|
2933 79 00 |
380917-97-5 |
perampanel |
|
2933 79 00 |
552292-08-7 |
rolapitant |
|
2933 79 00 |
425386-60-3 |
semagacestat |
|
2933 79 00 |
515814-01-4 |
voclosporin |
|
2933 99 80 |
481629-87-2 |
aleplasinin |
|
2933 99 80 |
394730-60-0 |
boceprevir |
|
2933 99 80 |
649735-63-7 |
brivanib alaninate |
|
2933 99 80 |
483369-58-0 |
denagliptin |
|
2933 99 80 |
284019-34-7 |
denibulin |
|
2933 99 80 |
481631-45-2 |
diaplasinin |
|
2933 99 80 |
272105-42-7 |
disitertide |
|
2933 99 80 |
227318-71-0 |
epetirimod |
|
2933 99 80 |
259793-96-9 |
favipiravir |
|
2933 99 80 |
871576-03-3 |
flovagatran |
|
2933 99 80 |
229305-39-9 |
golotimod |
|
2933 99 80 |
258818-34-7 |
larazotide |
|
2933 99 80 |
571170-77-9 |
laropiprant |
|
2933 99 80 |
616202-92-7 |
lorcaserin |
|
2933 99 80 |
868771-57-7 |
melogliptin |
|
2933 99 80 |
803712-67-6 |
obatoclax |
|
2933 99 80 |
404950-80-7 |
panobinostat |
|
2933 99 80 |
625114-41-2 |
piragliatin |
|
2933 99 80 |
74847-35-1 |
pyronaridine |
|
2933 99 80 |
872178-65-9 |
rabeximod |
|
2933 99 80 |
355151-12-1 |
rotigaptide |
|
2933 99 80 |
497221-38-2 |
rusalatide |
|
2933 99 80 |
187602-11-5 |
sofigatran |
|
2933 99 80 |
227318-75-4 |
sotirimod |
|
2933 99 80 |
402957-28-2 |
telaprevir |
|
2933 99 80 |
848084-83-3 |
tigapotide |
|
2933 99 80 |
393105-53-8 |
tiplasinin |
|
2933 99 80 |
620948-93-8 |
vabicaserin |
|
2933 99 80 |
794466-70-9 |
vernakalant |
|
2934 10 00 |
544417-40-5 |
capadenoson |
|
2934 10 00 |
302962-49-8 |
dasatinib |
|
2934 10 00 |
223132-37-4 |
inolitazone |
|
2934 10 00 |
241479-67-4 |
isavuconazole |
|
2934 10 00 |
338990-84-4 |
isavuconazonium chloride |
|
2934 10 00 |
607723-33-1 |
lobeglitazone |
|
2934 10 00 |
280782-97-0 |
managlinat dialanetil |
|
2934 10 00 |
790299-79-5 |
masitinib |
|
2934 10 00 |
223673-61-8 |
mirabegron |
|
2934 10 00 |
501948-05-6 |
rosabulin |
|
2934 10 00 |
447406-78-2 |
sodelglitazar |
|
2934 10 00 |
760937-92-6 |
teneligliptin |
|
2934 20 80 |
848344-36-5 |
bentamapimod |
|
2934 20 80 |
870093-23-5 |
talarozole |
|
2934 99 90 |
320345-99-1 |
aclidinium bromide |
|
2934 99 90 |
222551-17-9 |
adoprazine |
|
2934 99 90 |
207623-20-9 |
agatolimod |
|
2934 99 90 |
475479-34-6 |
aleglitazar |
|
2934 99 90 |
870524-46-2 |
amolimogene bepiplasmid |
|
2934 99 90 |
875446-37-0 |
anacetrapib |
|
2934 99 90 |
250386-15-3 |
apadenoson |
|
2934 99 90 |
541550-19-0 |
apilimod |
|
2934 99 90 |
160707-69-7 |
apricitabine |
|
2934 99 90 |
147403-03-0 |
azilsartan |
|
2934 99 90 |
863031-21-4 |
azilsartan medoxomil |
|
2934 99 90 |
757942-43-1 |
bederocin |
|
2934 99 90 |
627861-07-8 |
beperminogene perplasmid |
|
2934 99 90 |
959961-96-7 |
bevasiranib |
|
2934 99 90 |
769901-96-4 |
capeserod |
|
2934 99 90 |
868540-17-4 |
carfilzomib |
|
2934 99 90 |
872847-66-0 |
cenersen |
|
2934 99 90 |
80295-38-1 |
conestat alfa |
|
2934 99 90 |
903916-27-8 |
custirsen |
|
2934 99 90 |
187865-22-1 |
derquantel |
|
2934 99 90 |
134379-77-4 |
dexelvucitabine |
|
2934 99 90 |
247046-52-2 |
dilopetine |
|
2934 99 90 |
480449-70-5 |
edoxaban |
|
2934 99 90 |
188181-42-2 |
elacytarabine |
|
2934 99 90 |
98819-76-2 |
esreboxetine |
|
2934 99 90 |
763903-67-9 |
fosalvudine tidoxil |
|
2934 99 90 |
172673-20-0 |
fosaprepitant |
|
2934 99 90 |
522664-63-7 |
ibodutant |
|
2934 99 90 |
405159-59-3 |
idrabiotaparinux sodium |
|
2934 99 90 |
188116-07-6 |
imepitoin |
|
2934 99 90 |
335619-18-6 |
inakalant |
|
2934 99 90 |
1391-36-2 |
lancovutide |
|
2934 99 90 |
189059-71-0 |
lapaquistat |
|
2934 99 90 |
327026-93-7 |
lensiprazine |
|
2934 99 90 |
170632-47-0 |
lificiguat |
|
2934 99 90 |
852313-25-8 |
litenimod |
|
2934 99 90 |
1000120-98-8 |
mipomersen |
|
2934 99 90 |
62253-63-8 |
nepidermin |
|
2934 99 90 |
26833-87-4 |
omacetaxine mepesuccinate |
|
2934 99 90 |
269718-84-5 |
pardoprunox |
|
2934 99 90 |
219923-85-0 |
pramiconazole |
|
2934 99 90 |
377727-87-2 |
preladenant |
|
2934 99 90 |
524684-52-4 |
prinaberel |
|
2934 99 90 |
865311-47-3 |
quarfloxin |
|
2934 99 90 |
869884-78-6 |
radezolid |
|
2934 99 90 |
496054-87-6 |
radiprodil |
|
2934 99 90 |
518048-05-0 |
raltegravir |
|
2934 99 90 |
787548-03-2 |
regrelor |
|
2934 99 90 |
820957-38-8 |
retosiban |
|
2934 99 90 |
572924-54-0 |
ridaforolimus |
|
2934 99 90 |
128517-07-7 |
romidepsin |
|
2934 99 90 |
93265-81-7 |
ropidoxuridine |
|
2934 99 90 |
151823-14-2 |
sapacitabine |
|
2934 99 90 |
379231-04-6 |
saracatinib |
|
2934 99 90 |
791635-59-1 |
simotaxel |
|
2934 99 90 |
119567-79-2 |
taribavirin |
|
2934 99 90 |
332012-40-5 |
telatinib |
|
2934 99 90 |
925681-61-4 |
trabedersen |
|
2934 99 90 |
189003-92-7 |
trelanserin |
|
2934 99 90 |
296251-72-4 |
velimogene aliplasmid |
|
2934 99 90 |
904302-98-3 |
viquidacin |
|
2934 99 90 |
872525-61-6 |
votucalis |
|
2934 99 90 |
221877-54-9 |
zotarolimus |
|
2935 00 90 |
197904-84-0 |
apricoxib |
|
2935 00 90 |
769169-27-9 |
begacestat |
|
2935 00 90 |
414864-00-9 |
belinostat |
|
2935 00 90 |
313682-08-5 |
brecanavir |
|
2935 00 90 |
839673-52-8 |
cevoglitazar |
|
2935 00 90 |
358970-97-5 |
drinabant |
|
2935 00 90 |
865200-20-0 |
giripladib |
|
2935 00 90 |
464213-10-3 |
ibipinabant |
|
2935 00 90 |
173424-77-6 |
laromustine |
|
2935 00 90 |
398507-55-6 |
lodenafil carbonate |
|
2935 00 90 |
136564-68-6 |
masilukast |
|
2935 00 90 |
170569-88-7 |
mavacoxib |
|
2935 00 90 |
862189-95-5 |
mirodenafil |
|
2935 00 90 |
439687-69-1 |
nelivaptan |
|
2935 00 90 |
691852-58-1 |
nesbuvir |
|
2935 00 90 |
778576-62-8 |
oglemilast |
|
2935 00 90 |
444731-52-6 |
pazopanib |
|
2935 00 90 |
362505-84-8 |
relacatib |
|
2935 00 90 |
243984-11-4 |
resatorvid |
|
2935 00 90 |
519055-62-0 |
tasisulam |
|
2935 00 90 |
186497-07-4 |
zibotentan |
|
2936 29 00 |
104121-92-8 |
eldecalcitol |
|
2936 29 00 |
31690-09-2 |
levomefolic acid |
|
2937 19 00 |
782500-75-8 |
albiglutide |
|
2937 19 00 |
348119-84-6 |
obinepitide |
|
2937 19 00 |
295350-45-7 |
ozarelix |
|
2937 19 00 |
275371-94-3 |
taspoglutide |
|
2937 19 00 |
218949-48-5 |
tesamorelin |
|
2937 19 00 |
22006-64-0 |
tridecactide |
|
2937 22 00 |
132245-57-9 |
dexamethasone cipecilate |
|
2937 22 00 |
397864-44-7 |
fluticasone furoate |
|
2937 29 00 |
211254-73-8 |
lonaprisan |
|
2937 50 00 |
333963-42-1 |
cobiprostone |
|
2937 50 00 |
172740-14-6 |
posaraprost |
|
2937 90 00 |
834153-87-6 |
elagolix |
|
2937 90 00 |
609799-22-6 |
tasimelteon |
|
2937 90 00 |
342577-38-2 |
velneperit |
|
2939 19 00 |
73232-52-7 |
methylnaltrexone bromide |
|
2939 59 00 |
136199-02-5 |
rolofylline |
|
2939 99 00 |
850607-58-8 |
darotropium bromide |
|
2939 99 00 |
187852-63-7 |
delimotecan |
|
2940 00 00 |
9007-72-1 |
ferric carboxymaltose |
|
2940 00 00 |
442201-24-3 |
remogliflozin etabonate |
|
2940 00 00 |
408504-26-7 |
sergliflozin etabonate |
|
2941 90 00 |
467214-20-6 |
alvespimycin |
|
2941 90 00 |
677017-23-1 |
berubicin |
|
2941 90 00 |
229016-73-3 |
ceftaroline fosamil |
|
2941 90 00 |
318498-76-9 |
flopristin |
|
2941 90 00 |
145435-72-9 |
gamithromycin |
|
2941 90 00 |
325965-23-9 |
linopristin |
|
2941 90 00 |
857402-23-4 |
retaspimycin |
|
2941 90 00 |
305841-29-6 |
sagopilone |
|
2941 90 00 |
75747-14-7 |
tanespimycin |
|
2941 90 00 |
328898-40-4 |
tildipirosin |
|
2941 90 00 |
222400-20-6 |
tomopenem |
|
2941 90 00 |
63409-12-1 |
tylvalosin |
|
3001 90 91 |
9041-08-1 |
semuloparin sodium |
|
3002 10 91 |
792921-10-9 |
abagovomab |
|
3002 10 91 |
910649-32-0 |
anrukinzumab |
|
3002 10 91 |
648904-28-3 |
bavituximab |
|
3002 10 91 |
402710-27-4 (light chain) 402710-25-2 (heavy chain) |
canakinumab |
|
3002 10 99 |
945228-49-9 |
citatuzumab bogatox |
|
3002 10 91 |
880486-59-9 |
dacetuzumab |
|
3002 10 91 |
615258-40-7 |
denosumab |
|
3002 10 91 |
762260-74-2 |
efungumab |
|
3002 10 91 |
89957-37-9 |
gantenerumab |
|
3002 10 91 |
680188-33-4 |
ibalizumab |
|
3002 10 91 |
477202-00-9 |
ipilimumab |
|
3002 10 91 |
640735-09-7 |
iratumumab |
|
3002 10 91 |
845816-02-6 |
lexatumumab |
|
3002 10 91 |
903512-50-5 |
lucatumumab |
|
3002 10 91 |
899796-83-9 |
milatuzumab |
|
3002 10 91 |
677010-34-3 |
motavizumab |
|
3002 10 91 |
676258-98-3 |
naptumomab estafenatox |
|
3002 10 91 |
828933-51-3 |
nimotuzumab |
|
3002 10 91 |
949142-50-1 |
obinutuzumab |
|
3002 10 91 |
637334-45-3 |
ocrelizumab |
|
3002 10 91 |
881191-44-2 |
otelixizumab |
|
3002 10 91 |
372075-37-1 |
sontuzumab |
|
3002 10 91 |
705287-60-1 |
stamulumab |
|
3002 10 91 |
339086-80-5 |
tadocizumab |
|
3002 10 91 |
592557-43-2 (light chain) 592557-41-0 (heavy chain) |
tenatumomab |
|
3002 10 91 |
876387-05-2 |
teplizumab |
|
3002 10 91 |
918127-53-4 |
tigatuzumab |
|
3002 10 91 |
745013-59-6 |
tremelimumab |
|
3002 10 91 |
339986-90-2 |
tucotuzumab celmoleukin |
|
3002 10 91 |
728917-18-8 |
veltuzumab |
|
3002 10 91 |
896731-82-1 |
conatumumab |
|
3002 10 91 |
892553-42-3 |
etaracizumab |
|
3002 10 91 |
944548-38-3 |
foravirumab |
|
3002 10 91 |
944548-37-2 |
rafivirumab |
|
3002 10 91 |
880266-57-9 |
tanezumab |
|
3002 10 91 |
815610-63-0 |
ustekinumab |
|
3002 10 95 |
862111-32-8 |
aflibercept |
|
3002 10 95 |
845264-92-8 |
atacicept |
|
3002 10 95 |
909110-25-4 |
baminercept |
|
3002 10 95 |
9001-27-8 |
beroctocog alfa |
|
3002 10 95 |
879555-13-2 |
epoetin kappa |
|
3002 10 95 |
762263-14-9 |
epoetin theta |
|
3002 10 95 |
501081-76-1 |
rilonacept |
|
3002 10 95 |
267639-76-9 |
romiplostim |
|
3002 10 95 |
869858-13-9 |
thrombin alfa |
|
3002 10 95 |
897936-89-9 |
vatreptacog alfa (activated) |
|
3002 10 95 |
472960-22-8 |
albinterferon alfa-2b |
|
3002 10 95 |
869881-54-9 |
briobacept |
|
3002 10 95 |
606138-08-3 |
catridecacog |
|
3002 10 95 |
716840-32-3 |
denenicokin |
|
3002 10 95 |
931101-84-7 |
troplasminogen alfa |
|
3002 10 99 |
934216-54-3 |
alacizumab pegol |
|
3002 20 00 |
181477-43-0 |
disomotide |
|
3002 20 00 |
181477-91-8 |
ovemotide |
|
3002 20 00 |
915019-08-8 |
tertomotide |
|
3002 20 00 |
295371-00-5 |
verpasep caltespen |
|
3002 90 90 |
473553-86-5 |
alferminogene tadenovec |
|
3002 90 90 |
929881-05-0 |
alipogene tiparvovec |
|
3002 90 90 |
600735-73-7 |
contusugene ladenovec |
|
3002 90 90 |
851199-59-2 |
linaclotide |
|
3002 90 90 |
898830-54-1 |
sitimagene ceradenovec |
|
3002 90 90 |
721946-42-5 |
transferrin aldifitox |
|
3507 90 90 |
9026-00-0 |
bucelipase alfa |
|
3507 90 90 |
885051-90-1 |
pegloticase |
|
3507 90 90 |
884604-91-5 |
velaglucerase alfa |
|
3911 90 99 |
892497-01-7 |
azoximer bromide |
ANNEX II
List of prefixes and suffixes which, in combination with the INNs of Annex 3 to Annex I to Regulation (EEC) No 2658/87, describe the salts, esters or hydrates of INNs; these salts, esters and hydrates are free of duty, on condition that they are classifiable in the same six-digit HS subheading as the corresponding INN
The references to ‘International Nonproprietary Names (INN) for pharmaceutical substances, names for radicals and groups, comprehensive list 2004’ are replaced by ‘International Nonproprietary Names (INN) for pharmaceutical substances, names for radicals, groups and others, comprehensive list 2007’.
The following prefixes or suffixes are added to the list included in Annex 4 to Annex I to Regulation (EEC) No 2658/87:
|
Preferred prefix or suffix |
Synonym |
Systematic name when different |
|
alanetil (INNRG) |
|
[(S)-1-ethoxy-1-oxo-propan-2-yl]amino (INNCN) |
|
alaninate (INNRG) |
|
L-alaninate (INNCN) |
|
alapivoxil (INNRG) |
|
L-alanyl, [(2,2-dimethylpropanoyl)oxy]metyl (INNCN) |
|
aldifitox (INNRG) |
|
(4-iminobutane-1,4-diyl)sulfanediyl[(3RS)-2,5-dioxopyrrolidine-1,3-diyl]-1,3-phenylenecarbonyl and forming an N-benzoyl derivative of a primary amine group of diphtheria [550-L-phenylalanine]toxin from Corynebacterium diphtheriae-(26-560)-peptide (INNCN) |
|
besudotox (INNRG) |
|
L-lysyl-L-alanyl-L-serylglycylglycine (linker) fusion protein with des-(365-380)-[Asn364,Val407,Ser515,Gln590,Gln606,Arg613]exotoxin A (Pseudomonas aeruginosa)-(251-613)-peptide (toxin with region IA and first 16 residues of region IB deleted) (INNCN) |
|
ceribate (INNRG) |
|
rac-2,3-dihydroxypropyl carbonate (ester) (INNCN) |
|
cipecilate (INNRG) |
|
cyclohexanecarboxylate (ester), cyclopropanecarboxylate (ester) (INNCN) |
|
dalanated (INNRG) |
|
des-B30-alanine (INNCN) |
|
enacarbil (INNRG) |
|
{rac-1-[(2-methylpropanoyl)oxy]ethoxy}carbonyl (INNCN) |
|
estafenatox (INNRG) |
|
glycylglycyl-L-proline (linker) fusion protein with enterotoxin type A (Staphylococcus aureus)-(1-33)-peptidyl-L-seryl[Ser36,Ser37,Glu38,Lys39,Ala41,Thr46,Thr71,Ala72,Ser75,Glu76,Glu78,Ser80,Ser81,Thr214,Ser217,Thr219,Ser220,Ser222,Ser224]enterotoxin type E (Staphylococcus aureus)-(32-230)-peptide (synthetic superantigen SEA/E-120) (INNCN) |
|
etexilate (INNRG) |
|
ethyl, (hexyloxy)carbonyl |
|
fosamil (INNRG) |
|
phosphono (INNCN) |
|
glucuronide (INNRG) |
|
β-D-glucopyranosiduronic acid [oside] (INNCN) |
|
medocaril (INNRG) |
|
[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl (INNCN) |
|
paptox (INNRG) |
|
protein PAP (Phytolacca americana antiviral) (INNCN) |
|
placarbil (INNRG) |
|
(R)-2-methyl-1-[(2-methylpropanoyl)oxy]propoxy}carbonyl) (INNCN) |
The systematic name of the following prefix or suffix is amended as follows:
|
Preferred prefix or suffix |
Synonym |
Systematic name when different |
|
aritox (INNRG) |
|
ricin A chain (INNCN) |
ANNEX III
List of pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to be added to the list of products receiving duty-free treatment included in Annex 6 to Annex I to Regulation (EEC) No 2658/87
|
CN code |
CAS RN |
Name |
|
2843 29 00 |
22199-08-2 |
[4-amino-N-(pyrimidin-2(1H)-ylidene-κN1)benzenesulfonamidato-κO]silver |
|
2905 39 95 |
281214-27-5 |
(2R,3R)-2,3-dimethylbutane-1,4-diyl bis(4-methylbenzenesulfonate) |
|
2905 59 98 |
441002-17-1 |
4-chlorobutyl 2-nitrobenzenesulfonate |
|
2909 30 90 |
92878-95-0 |
2-(3-chloropropoxy)-1-methoxy-4-nitrobenzene |
|
2909 30 |
503070-57-3 |
2-({2-[(6-bromohexyl)oxy]ethoxy}methyl)-1,3-dichlorobenzene |
|
2909 30 |
461432-23-5 |
4-(5-bromo-2-chlorobenzyl)phenyl ethyl ether |
|
2909 49 80 |
185954-75-0 |
(3R)-3-methoxydecan-1-ol |
|
2909 49 80 |
85309-91-7 |
2-[(2,6-dichlorobenzyl)oxy]ethanol |
|
2909 49 80 |
160969-03-9 |
2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl methanesulfonate |
|
2909 50 00 |
167145-13-3 |
2-[2-(3-methoxyphenyl)ethyl]phenol |
|
2910 20 00 |
15448-47-2 |
(2R)-2-methyloxirane |
|
2910 90 00 |
62600-71-9 |
(2R)-2-(3-chlorophenyl)oxirane |
|
2910 90 00 |
702687-42-1 |
(2R)-2-[(5-bromo-2,3-difluorophenoxy)methyl]oxirane |
|
2910 90 00 |
683276-64-4 |
[(2R)-2-methyloxiran-2-yl]methyl 4-nitrobenzenesulfonate |
|
2913 00 00 |
90035-34-0 |
4′-(trifluoromethyl)biphenyl-4-carbaldehyde |
|
2914 40 90 |
17752-16-8 |
(3β)-3-hydroxycholest-5-en-24-one |
|
2914 50 00 |
974-23-2 |
(3β,16α)-3-hydroxy-16,17-epoxypregn-5-en-20-one |
|
2914 70 00 |
13054-81-4 |
4-chloro-heptane-3,5-dione |
|
2914 70 00 |
10226-30-9 |
6-chlorohexan-2-one |
|
2915 60 90 |
53064-79-2 |
iodomethyl pivalate |
|
2915 90 00 |
22328-90-1 |
(3R)-3-methylhexanoic acid |
|
2915 90 00 |
1069-66-5 |
sodium 2-propylpentanoate |
|
2916 20 00 |
211515-46-7 |
1-(2-ethylbutyl)cyclohexanecarbonyl chloride |
|
2916 20 00 |
381209-09-2 |
1-(2-ethylbutyl)cyclohexanecarboxylic acid |
|
2916 20 00 |
7077-05-6 |
trans-4-(propan-2-yl)cyclohexanecarboxylic acid |
|
2916 39 00 |
21900-39-0 |
5-fluoro-2-methylbenzoyl chloride |
|
2916 39 00 |
17625-03-5 |
sodium hydrogen 3-sulfonatobenzoate |
|
2917 19 90 |
76-72-2 |
diethyl ethyl(pentan-2-yl)propanedioate |
|
2918 29 00 |
376592-58-4 |
5′-chloro-2′-hydroxy-3′-nitrobiphenyl-3-carboxylic acid |
|
2918 99 90 |
709031-28-7 |
(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)(oxo)acetic acid |
|
2918 99 90 |
35480-52-5 |
2,5-bis(2,2,2-trifluoroethoxy)benzoic acid |
|
2918 99 90 |
4651-67-6 |
(3α,5β)-3-hydroxy-7-oxocholan-24-oic acid |
|
2918 99 90 |
52179-28-9 |
ethyl 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropanoate |
|
2918 99 90 |
530141-60-7 |
methyl 3-(5-{[4-(cyclopentyloxy)-2-hydroxyphenyl]carbonyl}-2-hydroxyphenyl)propanoate |
|
2920 90 10 |
91526-18-0 |
4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-one |
|
2921 49 00 |
334477-60-0 |
(1R)-1-[3,5-bis(trifluoromethyl)phenyl]-N-methylethanamine |
|
2921 49 00 |
376608-71-8 |
(1R,2S)-2-(3,4-difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate |
|
2921 49 00 |
1034457-07-2 |
2-(2,3-dihydro-1H-inden-2-yl)propan-2-amine hydrochloride |
|
2921 49 00 |
945717-05-5 |
2-(4-chloro-3-ethylphenyl)ethanamine hydrochloride |
|
2921 49 00 |
89-97-4 |
2-chlorobenzylamine |
|
2921 49 00 |
945717-43-1 |
N-(4-tert-butylbenzyl)-2-(4-chloro-3-ethylphenyl)ethanamine |
|
2921 51 90 |
150812-21-8 |
N4-[(4-fluorophenyl)methyl]-2-nitro-1,4-benzenediamine |
|
2922 19 85 |
1035455-90-3 |
(2R)-1-(5-bromo-2,3-difluorophenoxy)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}propan-2-ol hydrochloride |
|
2922 19 85 |
0-00-0 |
[2-(chloromethyl)-4-(dibenzylamino)phenyl]methanol hydrochloride |
|
2922 19 85 |
133-51-7 |
antimonic acid – 1-deoxy-1-(methylamino)-D-glucitol (1:1) |
|
2922 19 85 |
1035455-87-8 |
ethyl (2E)-3-(3-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}-4,5-difluorophenyl)prop-2-enoate hydrochloride |
|
2922 19 85 |
702686-97-3 |
ethyl 3-(3-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}-4,5-difluorophenyl)propanoate hydrochloride |
|
2922 29 00 |
20059-73-8 |
2-[4-(aminomethyl)phenoxy]-N,N-dimethylethanamine |
|
2922 49 85 |
848133-35-7 |
(2E)-4-(dimethylamino)but-2-enoic acid hydrochloride |
|
2922 49 85 |
610300-07-7 |
(3S,5R)-3-amino-5-methyloctanoic acid |
|
2922 49 85 |
610300-00-0 |
(3S,5R)-3-amino-5-methyloctanoic acid hydrochloride |
|
2922 49 85 |
143785-86-8 |
4-(1-aminocyclopropyl)-2,3,5-trifluorobenzoic acid |
|
2922 49 85 |
848949-85-9 |
4-fluoro-L-leucine – ethyl hydrogen sulfate (1:1) |
|
2922 49 85 |
39068-93-4 |
methyl 2-(dimethylamino)-2-phenylbutanoate |
|
2922 49 85 |
168619-25-8 |
methyl 3′-aminobiphenyl-3-carboxylate |
|
2922 49 85 |
82834-12-6 |
N-[(2S)-1-ethoxy-1-oxopentan-2-yl]-L-alanine |
|
2922 49 85 |
94133-84-3 |
sodium 2-amino-2-phenylbutanoate |
|
2922 50 00 |
503070-58-4 |
triphenylacetic acid – 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol (1:1) |
|
2924 19 00 |
62009-47-6 |
2-aminomalonamide |
|
2924 19 00 |
7355-58-0 |
N-(2-chloroethyl)acetamide |
|
2924 29 98 |
361442-00-4 |
{2-[(tert-butoxycarbonyl)amino]-3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl}acetic acid |
|
2924 29 98 |
266993-72-0 |
2,3-diaminobenzamide dihydrochloride |
|
2924 29 98 |
168080-49-7 |
2-chloro-4-{[(5-fluoro-2-methylphenyl)carbonyl]amino}benzoic acid |
|
2924 29 98 |
317374-08-6 |
2-methyl-4-{[(2-methylphenyl)carbonyl]amino}benzoic acid |
|
2924 29 98 |
143785-84-6 |
4-(1-carbamoylcyclopropyl)-2,3,5-trifluorobenzoic acid |
|
2924 29 98 |
143785-87-9 |
4-[1-(acetylamino)cyclopropyl]-2,3,5-trifluorobenzoic acid |
|
2924 29 98 |
108166-22-9 |
4-{[(2-methylphenyl)carbonyl]amino}benzoic acid |
|
2924 29 98 |
150812-23-0 |
ethyl {4-[(4-fluorobenzyl)amino]-2-nitrophenyl}carbamate |
|
2924 29 98 |
22316-45-6 |
ethyl 3-[(5-chloro-2-nitrophenyl)(phenyl)amino]-3-oxopropanoate |
|
2924 29 98 |
316173-29-2 |
methyl (1S,2S,3S,4R)-3-[(1S)-1-amino-2-ethylbutyl]-4-[(tert-butoxycarbonyl)amino]-2-hydroxycyclopentanecarboxylate |
|
2924 29 98 |
1142-20-7 |
N-benzyloxycarbonyl-L-alanine |
|
2924 29 98 |
84996-93-0 |
N-cyclohexyl-5-hydroxypentanamide |
|
2924 29 98 |
579494-66-9 |
propyl {4-[2-(diethylamino)-2-oxoethoxy]-3-ethoxyphenyl}acetate |
|
2925 19 95 |
265136-65-0 |
ethyl 3-amino-4-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]but-2-enoate |
|
2926 90 95 |
855425-38-6 |
1-(2-ethylbutyl)cyclohexanecarbonitrile |
|
2926 90 95 |
846023-24-3 |
2-cyano-N-(2,4-dichloro-5-methoxyphenyl)acetamide |
|
2926 90 95 |
591769-05-0 |
3-cyclopentylprop-2-enenitrile |
|
2926 90 95 |
20099-89-2 |
4-(bromoacetyl)benzonitrile |
|
2926 90 95 |
474554-45-5 |
4,5-diethoxy-3-fluorobenzene-1,2-dicarbonitrile |
|
2926 90 95 |
79370-78-8 |
5-hydroxybenzene-1,3-dicarbonitrile |
|
2926 90 95 |
139481-28-0 |
methyl 2-{[(2′-cyanobiphenyl-4-yl)methyl]amino}-3-nitrobenzoate |
|
2928 00 90 |
860035-10-5 |
1-({[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl}oxy)ethyl 2-methylpropanoate |
|
2928 00 90 |
910656-45-0 |
2-hydroxy-2-(trifluoromethyl)butanehydrazide |
|
2928 00 90 |
95759-10-7 |
4-chloro-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoic acid |
|
2928 00 90 |
473927-63-8 |
ethyl (2Z)-chloro[2-(4-methoxyphenyl)hydrazinylidene]ethanoate |
|
2928 00 90 |
158671-29-5 |
N,2-dihydroxy-4-methylbenzamide |
|
2928 00 90 |
84080-68-2 |
tert-butyl (2Z)-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoate |
|
2928 00 90 |
268544-50-9 |
tert-butyl-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoate |
|
2930 90 99 |
13459-62-6 |
{2-[(4-chlorophenyl)sulfanyl]phenyl}acetic acid |
|
2930 90 99 |
211513-21-2 |
1-(2-ethylbutyl)-N-(2-sulfanylphenyl)cyclohexanecarboxamide |
|
2930 90 99 |
860035-07-0 |
1-{[(methylsulfanyl)carbonyl]oxy}ethyl 2-methylpropanoate |
|
2930 90 99 |
893407-18-6 |
2,2,2-trifluoro-1-[4′-(methylsulfonyl)biphenyl-4-yl]ethanone |
|
2930 90 99 |
60759-00-4 |
3,4-diethoxybenzenecarbothioamide |
|
2930 90 99 |
21048-05-5 |
N-methylbenzenecarbothiohydrazide |
|
2931 00 99 |
13682-94-5 |
(2-bromoethenyl)(trimethyl)silane |
|
2931 00 99 |
914922-89-7 |
(2R,4R)-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-N-methoxy-N,2-dimethyl-7-oxoheptanamide |
|
2931 00 99 |
914922-88-6 |
(2R,4R)-4-{[tert-butyl(dimethyl)silyl]oxy}-N-methoxy-N,2-dimethyloct-7-enamide |
|
2931 00 99 |
871355-80-5 |
(4R)-2-bromo-7-{[tert-butyl(diphenyl)silyl]oxy}hept-1-en-4-yl 4-methylbenzenesulfonate |
|
2931 00 99 |
89694-48-4 |
(5-chloro-2-methoxyphenyl)boronic acid |
|
2931 00 99 |
701278-08-2 |
[(1R,5S)-5-[dimethyl(phenyl)silyl]-2-{[(2-methoxypropan-2-yl)oxy]methyl}cyclopent-2-en-1-yl]methanol |
|
2931 00 99 |
701278-09-3 |
{(4S,5R)-5-[(benzyloxy)methyl]-4-[dimethyl(phenyl)silyl]cyclopent-1-en-1-yl}methanol |
|
2931 00 99 |
796967-18-5 |
1-(2-fluoro-5-methylphenyl)-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea |
|
2931 00 99 |
172732-52-4 |
2-(1,3,2-dioxaborinan-2-yl)benzonitrile |
|
2931 00 99 |
185411-12-5 |
methyl 3-(trimethylsilyl)pent-4-enoate |
|
2932 19 00 |
253128-10-8 |
(1S)-1,5:7,10-dianhydro-12,13-bis-O-[tert-butyl(dimethyl)silyl]-2,3,4,6,8,11-hexadeoxy-1-{2-[(2S,5S)-5-(3-hydroxypropyl)-3-methylidenetetrahydrofuran-2-yl]ethyl}-3-methyl-9-O-methyl-4-methylidene-8-[(phenylsulfonyl)methyl]-D-arabino-D-altro-tridecitol |
|
2932 19 00 |
441045-17-6 |
(1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-bis(methylene)-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one methanesulfonate |
|
2932 29 85 |
916069-80-2 |
(4S)-4-(fluoromethyl)dihydrofuran-2(3H)-one |
|
2932 29 85 |
63106-93-4 |
1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one |
|
2932 29 85 |
7734-80-7 |
2-oxo-2H-chromene-6-carboxylic acid |
|
2932 29 85 |
0-00-0 |
4-(4-fluorophenyl)-7-(isothiocyanatomethyl)-2H-chromen-2-one |
|
2932 29 85 |
947408-91-5 |
6-[(2,4-dihydroxyphenyl)carbonyl]-2H-chromen-2-one |
|
2932 29 85 |
947408-90-4 |
6-[(2,4-dimethoxyphenyl)carbonyl]-2H-chromen-2-one |
|
2932 99 00 |
452342-08-4 |
(1R)-2-(benzylamino)-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)ethanol |
|
2932 99 00 |
99541-23-8 |
(1R,2S,3R,4R,5R)-4-azido-2-{[(4aR,6S,7R,8S,8aR)-7,8-bis(benzyloxy)-2-phenylhexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy}-6,8-dioxabicyclo[3.2.1]oct-3-yl acetate |
|
2932 99 00 |
461432-25-7 |
(1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol |
|
2932 99 00 |
196597-79-2 |
(2E)-1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylideneethanenitrile |
|
2932 99 00 |
3308-94-9 |
2-(3-chloropropyl)-2-(4-fluorophenyl)-1,3-dioxolane |
|
2932 99 00 |
274693-53-7 |
[(3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]carbamate |
|
2932 99 00 |
185954-98-7 |
[6(2Z,3R)]-3-O-decyl-2-deoxy-6-O-[2-deoxy-3-O-(3-metoxydecyl)-6-methyl-2-[(1-oxo-11-octadecenyl)amino]-4-O-phosphono-β-D-glucopyranosyl]-2-[(1,3-dioxotetradecyl)amino]-α-D-glucopyranose 1-(dihydrogen phosphate) tetrasodium salt |
|
2932 99 00 |
136172-58-2 |
1,6-di-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-D-glucopyranose |
|
2932 99 00 |
196597-80-5 |
2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethanamine hydrochloride |
|
2932 99 00 |
666860-59-9 |
2-amino-2-oxoethyl{3-[trans-5-(6-methoxynaphthalen-1-yl)-1,3-dioxan-2-yl]propyl}carbamate |
|
2932 99 00 |
117661-72-0 |
5-(chloromethyl)-6-methyl-1,3-benzodioxole |
|
2932 99 00 |
959624-24-9 |
6-(hydroxymethyl)-4-phenyl-3,4-dihydro-2H-chromen-2-ol |
|
2932 99 00 |
960404-59-5 |
but-2-yne-1,4-diol – methyl 1-C-[4-chloro-3-(4-ethoxybenzyl)phenyl]-α-D-glucopyranoside (1:1) |
|
2932 99 00 |
15826-37-6 |
disodium 5,5′-[(2-hydroxypropane-1,3-diyl)bis(oxy)]bis(4-oxo-4H-chromene-2-carboxylate) |
|
2932 99 00 |
204254-84-2 |
ethyl (3aR,7R,7aR)-2,2-dimethyl-7-[(methylsulfonyl)oxy]-3a,6,7,7a-tetrahydro-1,3-benzodioxole-5-carboxylate |
|
2932 99 00 |
99541-26-1 |
methyl (2S,3S,4S,5S,6S)-6-{[(1S,2S,3S,4R,5R)-3-(acetyloxy)-4-azido-6,8-dioxabicyclo[3.2.1]oct-2-yl]methyl}-4,5-bis(benzyloxy)-3-hydroxytetrahydro-2H-pyran-2-carboxylate |
|
2932 99 00 |
114869-97-5 |
methyl 6-O-acetyl-4-O-(2-O-acetyl-3-O-benzyl-6-methyl-α-L-idopyranuronosyl)-3-O-benzyl-2-{[(benzyloxy)carbonyl]amino}-2-deoxy-α-D-glucopyranoside |
|
2933 19 90 |
1035677-60-1 |
(4S)-3-(4-chlorophenyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide 2,3-dihydroxybutanedioate |
|
2933 19 90 |
18048-64-1 |
2-(3,4-dimethylphenyl)-5-methyl-2,4-dihydro-3H-pyrazol-3-one |
|
2933 19 90 |
1035675-24-1 |
3-(4-chlorophenyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide |
|
2933 19 90 |
1028026-83-6 |
5-methyl-1-(propan-2-yl)-4-[4-(propan-2-yloxy)benzyl]-1,2-dihydro-3H-pyrazol-3-one |
|
2933 19 90 |
473921-12-9 |
5-{[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy}benzene-1,3-dicarbonitrile |
|
2933 29 90 |
65902-59-2 |
2-bromo-4-nitro-1H-imidazole |
|
2933 29 90 |
57531-37-0 |
2-chloro-4-nitro-1H-imidazole |
|
2933 29 90 |
1000164-35-1 |
3-(1,1-dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-1-(triphenylmethyl)-L-histidyl-2-methylalanyl-L-α-glutamylglycine |
|
2933 29 90 |
152074-97-0 |
L-α-aspartyl-L-α-glutamyl-L-asparaginyl-L-prolyl-L-valyl-L-valyl-L-histidyl-L-phenylalanyl-L-phenylalanyl-L-lysyl-L-asparaginyl-L-isoleucyl-L-valyl-L-threonyl-L-prolyl-L-arginyl-L-threonine |
|
2933 29 90 |
781666-30-6 |
L-α-aspartyl-L-α-glutamyl-L-asparaginyl-L-prolyl-L-valyl-L-valyl-L-histidyl-L-phenylalanyl-L-phenylalanyl-L-lysyl-L-asparaginyl-L-isoleucyl-L-valyl-L-threonyl-L-prolyl-L-arginyl-L-threonine tetraacetate |
|
2933 29 90 |
451470-33-0 |
methyl 3′-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)biphenyl-3-carboxylate |
|
2933 39 99 |
925978-49-0 |
(+)-5-[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]-1-azabicyclo[3.2.1]octane |
|
2933 39 99 |
876170-44-4 |
(1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate |
|
2933 39 99 |
741705-70-4 |
(2R)-phenyl[(2R)-piperidin-2-yl]ethanoic acid hydrochloride |
|
2933 39 99 |
414910-13-7 |
(2S)-hydroxy(phenyl)ethanoic acid – (2R)-2-(4-fluoro-2-methylphenyl)piperidin-4-one (1:1) |
|
2933 39 99 |
0-00-0 |
(3aR,6aR)-1-(pyridin-3-yl)octahydropyrrolo[3,4-b]pyrrole 4-methylbenzenesulfonate |
|
2933 39 99 |
370882-57-8 |
(3aR,6aR)-1-(pyridin-3-yl)octahydropyrrolo[3,4-b]pyrrole dihydrochloride |
|
2933 39 99 |
334618-23-4 |
(3R)-piperidin-3-amine dihydrochloride |
|
2933 39 99 |
1062580-52-2 |
(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride |
|
2933 39 99 |
27262-47-1 |
(S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide |
|
2933 39 99 |
105812-81-5 |
[(3S,4R)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl]methanol |
|
2933 39 99 |
876068-51-8 |
[(3S,4S)-4-amino-1-(5,6-dichloropyridin-3-yl)pyrrolidin-3-yl]methanol |
|
2933 39 99 |
871022-14-9 |
1-({4-[({[2-oxo-3-(propan-2-yl)-2,3-dihydro-1H-benzimidazol-1-yl]carbonyl}amino)methyl]piperidin-1-yl}methyl)cyclobutanecarboxylic acid |
|
2933 39 99 |
5421-92-1 |
1-(pyridin-4-yl)pyridinium chloride hydrochloride |
|
2933 39 99 |
272776-12-2 |
1,1′-binaphthalene-2,2′-diol –5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole (1:1) |
|
2933 39 99 |
871022-19-4 |
1-[(4-{[(tert-butoxycarbonyl)amino]methyl}piperidin-1-yl)methyl]cyclobutanecarboxylic acid |
|
2933 39 99 |
3613-73-8 |
2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole |
|
2933 39 99 |
179687-79-7 |
2-[(2-chloro-4-nitrophenoxy)methyl]pyridine |
|
2933 39 99 |
122321-04-4 |
2-[methyl(pyridin-2-yl)amino]ethanol |
|
2933 39 99 |
945405-37-8 |
2-methyl-3-[(2S)-pyrrolidin-2-ylmethoxy]pyridine 2,3-dihydroxybutanedioate |
|
2933 39 99 |
936637-40-0 |
3,3′-piperidine-1,4-diyldipropan-1-ol 4-methylbenzenesulfonate |
|
2933 39 99 |
88150-62-3 |
3-ethyl-5-methyl-4-(2-chlorophenyl)-2-{[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]methyl}-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
|
2933 39 99 |
84100-54-9 |
4-(ethylamino)piperidine-4-carboxamide |
|
2933 39 99 |
873546-30-6 |
4,4′-[piperidine-1,4-diylbis(propane-3,1-diyloxy)]bis(N′-hydroxybenzenecarboximidamide) |
|
2933 39 99 |
873546-74-8 |
4,4′-[piperidine-1,4-diylbis(propane-3,1-diyloxy)]bis[N′-(acetyloxy)benzenecarboximidamide] |
|
2933 39 99 |
873546-38-4 |
4,4′-[piperidine-1,4-diylbis(propane-3,1-diyloxy)]dibenzenecarboximidamide trihydrochloride pentahydrate |
|
2933 39 99 |
873546-80-6 |
4,4′-[piperidine-1,4-diylbis(propane-3,1-diyloxy)]dibenzonitrile |
|
2933 39 99 |
78750-61-5 |
4-[(3-nitropyridin-2-yl)amino]phenol |
|
2933 39 99 |
866109-93-5 |
4-{4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl}phenol 4-methylbenzenesulfonate |
|
2933 39 99 |
927889-51-8 |
4-bromo-2,6-diethylpyridine 4-methylbenzenesulfonate |
|
2933 39 99 |
691882-47-0 |
4-hydroxybenzoic acid – (2S,4E)-N-methyl-5-[5-(propan-2-yloxy)pyridin-3-yl]pent-4-en-2-amine (1:1) |
|
2933 39 99 |
876068-46-1 |
5,6-dichloro-N-(2,2-dimethoxyethyl)pyridin-3-amine |
|
2933 39 99 |
1072-98-6 |
5-chloropyridin-2-amine |
|
2933 39 99 |
298692-34-9 |
6-(chloroacetyl)pyridine-2-carboxylic acid |
|
2933 39 99 |
550349-58-1 |
7-chloro-3-(6-methoxypyridin-3-yl)-N,N,5-trimethyl-4-oxo-4,5-dihydro-3H-pyridazino[4,5-b]indole-1-carboxamide |
|
2933 39 99 |
414909-98-1 |
benzyl 2-(4-fluoro-2-methylphenyl)-4-oxo-3,4-dihydropyridine-1(2H)-carboxylate |
|
2933 39 99 |
56880-11-6 |
ethyl [(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl)acetate |
|
2933 39 99 |
548797-97-3 |
N-(2-{[(2S)-3-{[1-(4-chlorobenzyl)piperidin-4-yl]amino}-2-hydroxy-2-methylpropyl]oxy}-4-hydroxyphenyl)acetamide |
|
2933 39 99 |
0-00-0 |
N-[(S)-1-azabicyclo[2.2.2]oct-2-yl(phenyl)methyl]-2,6-dichloro-3-(trifluoromethyl)benzamide hydrochloride |
|
2933 39 99 |
329003-65-8 |
sodium hydrogen [1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonate hemipentahydrate |
|
2933 49 10 |
417716-92-8 |
4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide methanesulfonate |
|
2933 49 90 |
503291-53-0 |
2-ethylbutyl (3S,4aS,6S,8aR)-6-[3-chloro-2-(1H-tetrazol-5-yl)phenoxy]decahydro-3-isoquinolinecarboxylate 4-methylbenzenesulfonate |
|
2933 49 90 |
103733-32-0 |
benzyl (3S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate hydrochloride |
|
2933 49 90 |
503293-98-9 |
(3S,4aS,6S,8aR)-6-hydroxy-2-(methoxycarbonyl)decahydroisoquinoline-3-carboxylic acid |
|
2933 49 90 |
503290-66-2 |
(3S,4aS,6S,8aR)-6-[3-chloro-2-(2H-tetrazol-5-yl)phenoxy]decahydro-3-isoquinolinecarboxylic acid hydrochloride |
|
2933 49 90 |
134388-95-7 |
(3S,4aS,8aR)-2-(methoxycarbonyl)-6-oxodecahydroisoquinoline-3-carboxylic acid – (1R)-1-phenylethanamine (1:1) |
|
2933 49 90 |
868210-14-4 |
4-(4-{[(2S,4R)-4-[acetyl(4-chlorophenyl)amino]-2-methyl-3,4-dihydroquinolin-1(2H)-yl]carbonyl}phenoxy)-2,2-dimethylbutanoic acid |
|
2933 49 90 |
00-00-0 |
methyl 2-[(3R)-3-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-({[1-(hydroxymethyl)cyclopropyl]methyl}sulfanyl)propyl]benzoate hydrochloride |
|
2933 49 90 |
848133-76-6 |
N-(4-chloro-3-cyano-7-ethoxyquinolin-6-yl)acetamide |
|
2933 59 95 |
869490-23-3 |
(3,3-difluoropyrrolidin-1-yl){(2S,4S)-4-[4-(pyrimidin-2-yl)piperazin-1-yl]pyrrolidin-2-yl}methanone |
|
2933 59 95 |
941685-40-1 |
(3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile |
|
2933 59 95 |
941678-49-5 |
(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile |
|
2933 59 95 |
941685-41-2 |
(3S)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile |
|
2933 59 95 |
957187-34-7 |
[(8R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]dec-9-yl]acetic acid |
|
2933 59 95 |
356058-42-9 |
{2-[(4-fluorobenzyl)sulfanyl]-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl}acetic acid |
|
2933 59 95 |
0-00-0 |
2,3-dihydroxy-2,3-bis(phenylcarbonyl)butanedioic acid – ethyl [(8R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]dec-9-yl]acetate (1:1) |
|
2933 59 95 |
90213-66-4 |
2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine |
|
2933 59 95 |
3934-20-1 |
2,4-dichloropyrimidine |
|
2933 59 95 |
451487-18-6 |
2-[(4-fluorobenzyl)sulfanyl]-1,5,6,7-tetrahydro-4H-cyclopenta[d]pyrimidin-4-one |
|
2933 59 95 |
865758-96-9 |
2-[(6-chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]benzonitrile |
|
2933 59 95 |
934815-71-1 |
2-[3-(6-{[2-(2,4-dichlorophenyl)ethyl]amino}-2-methoxypyrimidin-4-yl)phenyl]-2-methylpropanoic acid phosphate |
|
2933 59 95 |
722543-31-9 |
2-{ethyl[3-({4-[(5-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]quinazolin-7-yl}oxy)propyl]amino}ethyl dihydrogen phosphate |
|
2933 59 95 |
1032066-96-8 |
2-amino-9-{(1S,3R,4S)-3-[(benzyloxy)methyl]-4-[dimethyl(phenyl)silyl]-2-methylidenecyclopentyl}-1,9-dihydro-6H-purin-6-one – methanesulfonate (2:1) |
|
2933 59 95 |
540737-29-9 |
3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate |
|
2933 59 95 |
1137917-12-4 |
3-{[6-(ethylsulfonyl)pyridin-3-yl]oxy}-5-{[(2S)-1-hydroxypropan-2-yl]oxy}benzoic acid – 1,4-diazabicyclo[2.2.2]octane (2:1) |
|
2933 59 95 |
941685-39-8 |
3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile |
|
2933 59 95 |
941685-27-4 |
4-(1H-pyrazol-4-yl)-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine |
|
2933 59 95 |
1780-26-3 |
4,6-dichloro-2-methylpyrimidine |
|
2933 59 95 |
145783-14-8 |
4,6-dichloro-5-nitro-2-(propylsulfanyl)pyrimidine |
|
2933 59 95 |
3680-69-1 |
4-chloro-7H-pyrrolo[2,3-d]pyrimidine |
|
2933 59 95 |
61379-64-4 |
4-cyclopentylpiperazin-1-amine |
|
2933 59 95 |
55112-42-0 |
4-methylpiperazine-1-carbonyl chloride hydrochloride |
|
2933 59 95 |
0-00-0 |
5-(benzylamino)-2-(3-methoxyphenyl)-7-(4-methylpiperazin-1-yl)[1,2,4]triazolo[1,5-a]quinoline-4-carbonitrile – (2E)-but-2-enedioate (2:1) hydrate |
|
2933 59 95 |
55293-96-4 |
5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine-2-carbaldehyde |
|
2933 59 95 |
179688-01-8 |
7-(benzyloxy)-6-methoxyquinazolin-4(3H)-one |
|
2933 59 95 |
444731-74-2 |
N-(2-chloropyrimidin-4-yl)-2,3-dimethyl-2H-indazol-6-amine |
|
2933 59 95 |
0-00-0 |
N-(5-fluoro-3-methyl-1H-indol-1-yl)-4-methyl-2-(pyridin-2-yl)pyrimidine-5-carboxamide |
|
2933 79 00 |
586414-48-4 |
(-)-3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl}-N,4-dimethylbenzamide |
|
2933 79 00 |
425663-71-4 |
(1S)-1-amino-3-methyl-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one hydrochloride |
|
2933 79 00 |
813452-14-1 |
(4S)-1-[(2S,3S,11bS)-2-amino-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-3-yl]-4-(fluoromethyl)pyrrolidin-2-one dihydrochloride |
|
2933 79 00 |
5162-90-3 |
3-(2-oxo-1,2-dihydroquinolin-4-yl)alanine |
|
2933 79 00 |
536760-29-9 |
3-chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one |
|
2933 79 00 |
4876-10-2 |
4-(bromomethyl)quinolin-2(1H)-one |
|
2933 79 00 |
5057-12-5 |
4,6,7,8-tetrahydroquinoline-2,5(1H,3H)-dione |
|
2933 79 00 |
54197-66-9 |
6-hydroxy-3,4-dihydroquinolin-2(1H)-one |
|
2933 79 00 |
22246-18-0 |
7-hydroxy-3,4-dihydroquinolin-2(1H)-one |
|
2933 79 00 |
536759-91-8 |
ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |
|
2933 79 00 |
503614-91-3 |
ethyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |
|
2933 79 00 |
586379-61-5 |
methyl 3-(4-hydroxy-6-methyl-2-oxopyridin-1(2H)-yl)-4-methylbenzoate |
|
2933 99 80 |
709031-45-8 |
(1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-carboxamide methanesulfonate |
|
2933 99 80 |
649735-46-6 |
(2R)-1-({4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl}oxy)propan-2-ol |
|
2933 99 80 |
51077-14-6 |
(2S)-1-(tert-butoxycarbonyl)azetidine-2-carboxylic acid |
|
2933 99 80 |
631916-97-7 |
(2S)-N-{4-[(Z)-amino(methoxyimino)methyl]benzyl}-1-{(2R)-2-[3-chloro-5-(difluoromethoxy)phenyl]-2-hydroxyethanoyl}azetidine-2-carboxamide – benzenesulphonic acid (1:1) |
|
2933 99 80 |
80875-98-5 |
(2S,3aS,7aS)-octahydro-1H-indole-2-carboxylic acid |
|
2933 99 80 |
948846-40-0 |
(2S,3S)-2,3-bis[(phenylcarbonyl)oxy]butanedioic acid – ethyl (3aR,6aR)-hexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxylate (1:1) |
|
2933 99 80 |
1000164-36-2 |
(5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S)-5-(3-amino-3-oxopropyl)-20-benzyl-23-[(2S)-butan-2-yl]-14,38-bis{4-[(tert-butoxycarbonyl)amino]butyl}-29-{[1-(tert-butoxycarbonyl)-1H-indol-3-yl]methyl}-17-(3-tert-butoxy-3-oxopropyl)-1-(1H-fluoren-9-yl)-8,11,26,41,41-pentamethyl-32-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-35-(propan-2-yl)-2-oxa-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecaazadotetracontan-42-oic acid |
|
2933 99 80 |
22162-51-2 |
1-(2-nitrobenzyl)-1H-pyrrole-2-carbaldehyde |
|
2933 99 80 |
35681-40-4 |
1-(propan-2-yl)-1,3-dihydro-2H-benzimidazol-2-one |
|
2933 99 80 |
166170-15-6 |
1-(tert-butoxycarbonyl)-2-methyl-D-proline |
|
2933 99 80 |
796967-16-3 |
1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea |
|
2933 99 80 |
0-00-0 |
1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea hydrochloride |
|
2933 99 80 |
444731-72-0 |
2,3-dimethyl-2H-indazol-6-amine |
|
2933 99 80 |
19686-05-6 |
2,8-dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole |
|
2933 99 80 |
912444-00-9 |
2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide |
|
2933 99 80 |
912445-36-4 |
2-[(2S)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide dihydrochloride |
|
2933 99 80 |
163457-23-6 |
3,3-difluoropyrrolidine hydrochloride |
|
2933 99 80 |
239463-85-5 |
3-{5-[(2R)-2-aminopropyl]-7-cyano-2,3-dihydro-1H-indol-1-yl}propyl benzoate (2R,3R)-2,3-dihydroxybutanedioate |
|
2933 99 80 |
55321-99-8 |
3-oxo-3,4-dihydropyrazine-2-carboxamide |
|
2933 99 80 |
952490-01-6 |
4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl 2,2-dimethylpropanoate |
|
2933 99 80 |
942436-93-3 |
4-amino-8-(2,5-dimethoxyphenyl)-N-propylcinnoline-3-carboxamide |
|
2933 99 80 |
942437-37-8 |
4-amino-8-(2-fluoro-6-methoxyphenyl)-N-propylcinnoline-3-carboxamide |
|
2933 99 80 |
288385-88-6 |
4-fluoro-2-methyl-1H-indol-5-ol |
|
2933 99 80 |
503293-47-8 |
5-(2-chloro-6-fluorophenyl)-2H-tetrazole |
|
2933 99 80 |
73963-42-5 |
5-(4-chlorobutyl)-1-cyclohexyl-1H-tetrazole |
|
2933 99 80 |
606143-52-6 |
5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide |
|
2933 99 80 |
0-00-0 |
5-fluoro-1-(3-fluorobenzyl)-N-(1H-indol-5-yl)-1H-indole-2-carboxamide |
|
2933 99 80 |
872206-47-8 |
5-methyl-4-oxo-1,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl 2,2-dimethylpropanoate |
|
2933 99 80 |
259793-88-9 |
6-bromo-3-oxo-3,4-dihydropyrazine-2-carboxamide |
|
2933 99 80 |
1137606-74-6 |
6-fluoro-3-oxo-3,4-dihydropyrazine-2-carbonitrile – N-cyclohexylcyclohexanamine (1:1) |
|
2933 99 80 |
261953-36-0 |
6-iodo-1H-indazole |
|
2933 99 80 |
80076-47-7 |
8,9-difluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid |
|
2933 99 80 |
52602-39-8 |
9H-carbazol-4-ol |
|
2933 99 80 |
145641-35-6 |
benzyl (2S,3aR,7aS)-octahydro-1H-indole-2-carboxylate hydrochloride |
|
2933 99 80 |
87269-87-2 |
benzyl (2S,3aS,6aS)-octahydrocyclopenta[b]pyrrole-2-carboxylate hydrochloride |
|
2933 99 80 |
1012065-72-3 |
ethyl 2-amino-9,10-dimethoxy-1,6,7,11b-tetrahydro-4H-pyrido[2,1-a]isoquinoline-3-carboxylate |
|
2933 99 80 |
131707-24-9 |
ethyl 6-bromo-5-hydroxy-1-methyl-2-[(phenylsulfanyl)methyl]-1H-indole-3-carboxylate |
|
2933 99 80 |
105152-95-2 |
ethyl 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate |
|
2933 99 80 |
139481-44-0 |
methyl 1-[(2′-cyanobiphenyl-4-yl)methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate |
|
2933 99 80 |
0-00-0 |
methyl 1-tert-butyl-2-hydroxy-1H-pyrrolo[2,3-b]pyridine-3-carboxylate |
|
2933 99 80 |
21688-11-9 |
N2-[(benzyloxy)carbonyl]-L-glutaminyl-L-asparaginyl-S-benzyl-L-cysteinyl-L-prolyl-L-leucylglycinamide |
|
2933 99 80 |
361440-67-7 |
tert-butyl (1S,3S,5S)-3-carbamoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate |
|
2933 99 80 |
709031-38-9 |
tert-butyl (2S)-2-carbamoyl-2,3-dihydro-1H-pyrrole-1-carboxylate |
|
2933 99 80 |
709031-43-6 |
tert-butyl [(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)-2-oxoethyl]carbamate |
|
2933 49 90 |
936359-25-0 |
methyl 2-((R)-3-(3-((E)-2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(((1-(hydroxymethyl)cyclopropyl)methyl)sulfanyl)propyl)benzoate |
|
2934 10 00 |
110130-88-6 |
(2Z)-[(acetyloxy)imino](2-amino-1,3-thiazol-4-yl)ethanoic acid |
|
2934 10 00 |
68672-66-2 |
(2Z)-{[(1-tert-butoxy-2-methyl-1-oxopropan-2-yl)oxy]imino}[2-(tritylamino)-1,3-thiazol-4-yl]ethanoic acid |
|
2934 10 00 |
291536-35-1 |
(5Z)-5-(4-fluorobenzylidene)-1,3-thiazolidine-2,4-dione |
|
2934 10 00 |
302964-24-5 |
2-amino-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide |
|
2934 10 00 |
866920-24-3 |
3-[2-chloro-4-({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methoxy)phenyl]-1,2,4-oxadiazol-5(4H)-one |
|
2934 10 00 |
752253-39-7 |
4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-(prop-2-yn-1-yl)-1,3-thiazol-2-amine |
|
2934 10 00 |
914361-45-8 |
L-lysine – {[(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-yl]oxy}methyl dihydrogen phosphate – ethanol (1:1:1) |
|
2934 10 00 |
302964-08-5 |
N-(2-chloro-6-methylphenyl)-2-[(6-chloro-2-methylpyrimidin-4-yl)amino]-1,3-thiazole-5-carboxamide |
|
2934 10 00 |
127660-04-2 |
sodium (2Z)-(2-amino-1,3-thiazol-4-yl)(hydroxyimino)ethanoate |
|
2934 99 90 |
17381-54-3 |
(1-benzothiophen-5-yl)acetic acid |
|
2934 99 90 |
630100-90-2 |
(1R)-1,2-anhydro-4-C-{(1E,3E)-4-[(1S,2S,3E,5R,6R,9R)-5-(1-carboxylato-4-cycloheptylpiperazin-2-yl)-6,9-dihydroxy-2,6-dimethyl-11-oxooxacyclododec-3-en-1-yl]penta-1,3-dien-1-yl}-3,5-dideoxy-1-[(2R,3S)-3-hydroxypentan-2-yl]-D-erythropentitol |
|
2934 99 90 |
220099-91-2 |
(2R)-3′H-spiro[4-azabicyclo[2.2.2]octane-2,2′-furo[2,3-b]pyridine] |
|
2934 99 90 |
220100-81-2 |
(2R)-3′H-spiro[4-azabicyclo[2.2.2]octane-2,2′-furo[2,3-b]pyridine] (S,S)-2,3-dihydroxybutanedioate |
|
2934 99 90 |
161599-46-8 |
(2R,3R,4R,5R)-2-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-2-fluoro-5-methyltetrahydrofuran-3,4-diyl diacetate |
|
2934 99 90 |
690270-65-6 |
(2R,3S,4R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-azido-2-{[(2-methylpropanoyl)oxy]methyl}tetrahydrofuran-3,4-diyl bis(2-methylpropanoate) hydrochloride |
|
2934 99 90 |
265121-04-8 |
(3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(2-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid – 1-deoxy-1-(methylamino)-D-glucitol (1:2) |
|
2934 99 90 |
163680-80-6 |
(3S)-10-[1-(acetylamino)cyclopropyl]-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid |
|
2934 99 90 |
132335-46-7 |
(3S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine |
|
2934 99 90 |
133413-70-4 |
(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-4,10,12,16,22,24-hexamethyl-3,9,15,21-tetrakis(2-methylpropyl)-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclotetracosane-2,5,8,11,14,17,20,23-octone |
|
2934 99 90 |
503068-36-8 |
(5R)-3-(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one |
|
2934 99 90 |
452339-73-0 |
(5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one |
|
2934 99 90 |
877130-28-4 |
(6R)-6-cyclopentyl-6-[2-(2,6-diethylpyridin-4-yl)ethyl]-3-[(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl]-4-hydroxy-5,6-dihydro-2H-pyran-2-one |
|
2934 99 90 |
132335-44-5 |
(S)-3-(dimethylamino)-1-(thiophen-2-yl)propan-1-ol |
|
2934 99 90 |
812647-80-6 |
{(2R,3S,4R,5R)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-bis[(phenylcarbonyl)oxy]tetrahydrofuran-2-yl}methyl 3-chlorobenzoate |
|
2934 99 90 |
00-00-0 |
1-(1-{4-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]butyl}-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-2H-benzimidazol-2-one |
|
2934 99 90 |
1029716-44-6 |
1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole |
|
2934 99 90 |
165172-60-1 |
1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione – 1-methylpyrrolidin-2-one (1:1) |
|
2934 99 90 |
519187-97-4 |
1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-3-azetidinol – (2Z)-2-butenedioate (1:1) |
|
2934 99 90 |
127000-90-2 |
1-{[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl]methyl}-1H-1,2,4-triazole |
|
2934 99 90 |
710281-33-7 |
2-({[(1R,3S)-3-{[2-(3-methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methoxy}cyclohexyl]oxy}methyl)-6-methylbenzoic acid |
|
2934 99 90 |
96803-30-4 |
2-(1-benzothiophen-5-yl)ethanol |
|
2934 99 90 |
913695-00-8 |
2-[({4-[(2,2-dimethyl-1,3-dioxan-5-yl)methoxy]-3,5-dimethylpyridin-2-yl}methyl)sulfinyl]-1Hbenzimidazole, sodium salt (1:1) |
|
2934 99 90 |
376608-74-1 |
2-{[(3aR,4S,6R,6aS)-6-{[5-amino-6-chloro-2-(propylsulfanyl)pyrimidin-4-yl]amino}-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy}ethanol |
|
2934 99 90 |
474554-48-8 |
2-bromo-1-[3-tert-butyl-4-methoxy-5-(morpholin-4-yl)phenyl]ethanone |
|
2934 99 90 |
530141-72-1 |
3-(5-{[4-(cyclopentyloxy)-2-hydroxyphenyl]carbonyl}-2-[(3-hydroxy-1,2-benzoxazol-6-yl)methoxy]phenyl)propanoic acid |
|
2934 99 90 |
519188-55-7 |
3-[2-(1-benzothiophen-5-yl)ethoxy]-1-(3-hydroxyazetidin-1-yl)propan-1-one |
|
2934 99 90 |
519188-42-2 |
3-[2-(1-benzothiophen-5-yl)ethoxy]propionic acid |
|
2934 99 90 |
753015-42-8 |
3-{(E)-2-[(3R)-pyrrolidin-3-yl]ethenyl}-5-(tetrahydro-2H-pyran-4-yloxy)pyridine |
|
2934 99 90 |
26638-53-9 |
3-chloro-6-methyldibenzo[c,f][1,2]thiazepin-11(6H)-one 5,5-dioxide |
|
2934 99 90 |
499785-81-8 |
3-oxo-4-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-3,4-dihydropyrazine-2-carboxamide |
|
2934 99 90 |
356782-84-8 |
3-oxo-4-(β-D-ribofuranosyl)-3,4-dihydropyrazine-2-carboxamide |
|
2934 99 90 |
6504-57-0 |
4-[3-hydroxy-3-phenyl-3-(thiophen-2-yl)propyl]-4-methylmorpholin-4-ium methyl sulfate |
|
2934 99 90 |
871484-32-1 |
4-[4-({3-[(4-deoxy-4-fluoro-b-D-glucopyranosyl)oxy]-5-(propan-2-yl)-1H-pyrazol-4-yl}methyl)phenyl]-N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]butanamide |
|
2934 99 90 |
166964-09-6 |
4-chloro-3-methyl-1,2-oxazol-5-amine |
|
2934 99 90 |
655233-39-3 |
4-nitrobenzyl(6R,7R)-7-amino-8-oxo-3-[(2S)-tetrahydrofuran-2-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride |
|
2920 90 85 |
89729-09-9 |
5,7-dioxa-6-thiaspiro[2.5]octane-6-oxide |
|
2934 99 90 |
388082-75-5 |
5-[4-[[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furancarboxaldehyde – 4-methylbenzenesulfonate (1:1) |
|
2934 99 90 |
4923-87-9 |
5-bromo-1-benzothiophene |
|
2934 99 90 |
947408-95-9 |
6-(bromomethyl)-2-triphenylmethyl-1,2-benzisoxazol-3(2H)-one |
|
2934 99 90 |
947408-94-8 |
6-methyl-2-trityl-1,2-benzoxazol-3(2H)-one |
|
2934 99 90 |
67978-05-6 |
diphenylmethyl(2R)-3-methyl-2-[(1R,5S)-3-(4-methylphenyl)-7-oxo-4-oxa-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl]but-3-enoate |
|
2934 99 90 |
1001859-46-6 |
DNA (synthetic plasmid vector pCOR human interferon beta signal peptide fusion protein with 21-154-human acidic fibroblast growth factor-specifying) |
|
2934 99 90 |
665058-78-6 |
DNA, d(T-sp-C-G-sp-T-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-G-sp-A-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-Gsp-T-sp-C-G-sp-T-sp-T) |
|
2934 99 90 |
923591-06-4 |
methyl (5R,7S,10S)-10-tert-butyl-15,15-dimethyl-3,9,12-trioxo-6,7,9,10,11,12,14,15,16,17,18,19-dodecahydro-1H,5H-2,23:5,8-dimethano-4,13,2,8,11-benzodioxatriazacyclohenicosine-7(3H)-carboxylate |
|
2934 99 90 |
59337-92-7 |
methyl 3-(chlorosulfonyl)thiophene-2-carboxylate |
|
2934 99 90 |
947409-01-0 |
methyl 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(2-triphenylmethyl-1,2-benzisoxazol-3(2H)-on-6-yl)methoxy]phenyl]propionate |
|
2934 99 90 |
85006-31-1 |
methyl 3-amino-4-methylthiophene-2-carboxylate |
|
2934 99 90 |
893428-72-3 |
N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine – (2E)-2-butenedioate (1:2) |
|
2934 99 90 |
390800-88-1 |
N,N′,N′′-(boroxin-2,4,6-triyltris{[(1S)-3-methylbutane-1,1-diyl]imino[(2S)-1-oxo-3-phenylpropane-1,2-diyl]})tripyrazine-2-carboxamide |
|
2934 99 90 |
112913-94-7 |
N-{[4-(4-fluorobenzyl)morpholin-2-yl]methyl}acetamide |
|
2934 99 90 |
120788-03-6 |
S-[(1R,3S)-1-oxidotetrahydrothiophen-3-yl] ethanethioate |
|
2935 00 90 |
1198178-65-2 |
(1R,2R)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethylcyclopropanaminium 4-methylbenzenesulfonate |
|
2935 00 90 |
39570-96-2 |
(2R)-3-(benzylsulfanyl)-N-[(2S)-1-{[(2S,3S)-1-hydrazinyl-3-methyl-1-oxopentan-2-yl]amino}-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-2-{[(4-methylphenyl)sulfonyl]amino}propanamide |
|
2935 00 90 |
24310-36-9 |
1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one |
|
2935 00 90 |
0-00-0 |
2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide di[(2E)-but-2-enedioate] hydrate |
|
2935 00 90 |
941690-55-7 |
3-[(methylsulfonyl)amino]-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide |
|
2935 00 90 |
6973-09-7 |
5-amino-2-methylbenzenesulfonamide |
|
2935 00 90 |
193686-76-9 |
7-chloro-1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one |
|
2935 00 90 |
123664-84-6 |
N-(5-methoxy-2-phenoxyphenyl)methanesulfonamide |
|
2935 00 90 |
149457-03-4 |
N-[4-(N-formylglycyl)-5-hydroxy-2-phenoxyphenyl]methanesulfonamide |
|
2935 00 90 |
149456-98-4 |
N-[4-(N-formylglycyl)-5-methoxy-2-phenoxyphenyl]methanesulfonamide |
|
2935 00 90 |
141450-48-8 |
N-{2-[(4-hydroxyphenyl)amino]pyridin-3-yl}-4-methoxybenzenesulfonamide hydrochloride |
|
2935 00 90 |
289042-10-0 |
N-{5-[(diphenylphosphoryl)methyl]-4-(4-fluorophenyl)-6-(propan-2-yl)pyrimidin-2-yl}-N-methylmethanesulfonamide |
|
2939 99 00 |
7689-03-4 |
(4S)-4-ethyl-4-hydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione |
|
2939 99 00 |
477-29-2 |
colchicoside |
|
2940 00 00 |
604-69-3 |
1,2,3,4,6-penta-O-acetyl-β-D-glucopyranose |
|
2940 00 00 |
647834-15-9 |
2-(4-methoxybenzyl)thiophen-3-yl β-D-glucopyranoside |
|
2941 90 00 |
76610-92-9 |
(6R,7R)-7-({N-[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]-D-threonyl}amino)-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
|
3907 20 99 |
913976-27-9 |
poly(oxy-1,2-ethanediyl), α-hydro-ω-methoxy, diester with 21N6, 21′N6-[[(N2, N6-dicarboxy-L-lysyl-β-alanyl)imino]bis(1-oxo-2, 1-ethanediyl)]bis[N-acetylglycyl-L-leucyl-L-tyrosyl-L-alanyl-L-cysteinyl-L-histidyl-L-methionylglycyl-L-prolyl-L-isoleucyl-L-threonyl-3-(1-naphthalenyl)-L-alanyl-L-valyl-L-cysteinyl-L-glutaminyl-L-prolyl-L-leucyl-L-arginyl-N-methylglycyl-L-lysinamide] cyclic (6→15), (6′→15′) bis(disulfide) |
ANNEX IV
List of pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to be withdrawn from the list of products receiving duty-free treatment included in Annex 6 to Annex I to Regulation (EEC) No 2658/87 due to their transfer to the list of products receiving duty-free treatment included in Annex 3 to Annex I to Regulation (EEC) No 2658/87
|
CN code |
CAS RN |
Name |
|
2915 39 00 2937 29 00 |
7753-60-8 |
17-alpha-hydroxy-3,20-dioxopregna-4,9(11)-diene-21-yl acetate see anecortave (INN) |
|
2920 90 85 |
163133-43-5 |
4-(nitrooxy)butyl (2S)-2-(6-methoxy-2-naphthyl) propanoate see naproxcinod (INN) |
|
2924 29 98 |
194085-75-1 |
2-(2-chlorophenyl)-2-hydroxyethyl carbamate see carisbamate (INN) |
|
2933 39 99 |
103129-82-4 |
3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate see levamlodipine (INN) |
|
2933 39 99 |
319460-85-0 |
N-methyl-2-{[3-((E)-2-pyridin-2-ylvinyl)-1H-indazol-6-yl]sulfanyl}benzamide see axitinib (INN) |
|
2934 10 00 |
302962-49-8 |
N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)thiazole-5-carboxamide see dasatinib (INN) |
|
2934 99 90 |
143491-57-0 |
(2R,5S)-4-amino-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one see emtricitabine(INN) |
|
2934 99 90 |
98819-76-2 |
(2S)-2-[(S)-(2-ethoxyphenoxy)phenylmethyl]morpholine see esreboxetine (INN) |
|
2934 99 90 |
475479-34-6 |
(2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid see aleglitazar (INN) |
|
2934 99 90 |
377727-87-2 |
2-(2-furyl)-7-(2-{4-[4-(2-methoxyethoxy)phenyl] piperazin-1-yl}ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[2,3-c]pyrimidin-5-amine see preladenant (INN) |
|
2934 99 90 |
189003-92-7 |
2-{7-fluoro-2-oxo-4-[2-(4-thieno[3,2-c]pyridin-4-ylpiperazin-1-yl)ethyl]quinolin-1(2H)-yl}acetamide see trelanserin (INN) |
|
2934 99 90 |
134379-77-4 |
4-amino-5-fluoro-1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]pyrimidin-2(1H)-one see dexelvucitabine (INN) |
|
2934 99 90 |
518048-05-0 |
potassium 4-[N-(2-fluorobenzyl)carbamoyl]-1-methyl-2-[1-methyl-1-(5-methyl-1,3,4-oxadiazole-2-carboxamido)ethyl]-6-oxo-1,6-dihydropyrimidine-5-olate see raltegravir (INN) |
|
2935 00 90 |
170569-88-7 |
4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzene-1-sulfonamide see mavacoxib (INN) |
|
2935 00 90 |
186497-07-4 |
N-(3-methoxy-5-methylpyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide see zibotentan (INN) |